ClinicalTrials.gg
Not yet recruitingNCT07385872Updated Feb 4, 2026

Performance of a Novel Concept for Internal Fixation of a Novel Peripheral Nerve Block Catheter

An interventional study of Novel Internal Fixation Nerve Block Catheter - Sciatic Nerve and Novel Internal Fixation Nerve Block Catheter - Saphenous nerve in Primary Condition: Nerve Block, Secondary Condition: Catheter Displacement and Focus of Study: Sciatic Nerve, sponsored by Nordsjaellands Hospital. Not yet recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.

Sponsored by Nordsjaellands Hospital · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Aug 2026, 3 months ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to test a new type of nerve block catheter (a thin, flexible tube used to deliver pain medication). Researchers want to see if this new design stays in its original position better than current catheters and if it is easy for doctors to use.

The main questions the study aims to answer are:

Does the catheter tip stay in the correct position over time without moving or slipping (dislocation)?

Can the catheter be placed quickly and accurately using the new deployment system?

Researchers will test this prototype in a small group of participants. There is no comparison group for this initial study.

Participants will:

Have the catheter placed near a nerve in their leg a few days before a scheduled femoral (leg) amputation.

Undergo imaging or checks to see if the catheter has moved.

Have the catheter removed just before their scheduled surgery.

The catheter will be placed in an area of the leg that is already scheduled to be removed during surgery. This ensures that the study carries minimal risk to the participants.

Read the detailed description

Background and Rationale Peripheral nerve blocks are a standard of care for regional anesthesia; however, traditional catheters are prone to secondary dislocation (slipping out of place), which leads to inadequate pain control. This study evaluates a novel prototype catheter designed with an internal fixation mechanism intended to secure the catheter tip at the target site. Additionally, the system utilizes a refined deployment mechanism designed for rapid and precise placement by the clinician.

Study Objective The primary objective of this pilot study is to evaluate the stability and migration rate of the catheter tip over a multi-day period. Secondarily, the study will assess the technical feasibility and speed of the deployment system.

Study Design and Safety Model This is a single-arm, non-randomized, proof-of-concept trial. To ensure maximum participant safety during the testing of this new hardware, the study utilizes a femoral amputation model.

The catheter will be placed in participants who are already scheduled for a femoral amputation. The insertion site and the final position of the catheter tip will be located distal to (below) the anticipated surgical amputation line. This ensures that the tissue involved in the study is part of the limb intended for removal, thereby minimizing any long-term risk of nerve injury or local tissue complications for the participant.

Procedures

Baseline \& Placement: Eligible participants will have the prototype catheter placed via ultrasound guidance several days prior to their scheduled surgery. The time required for deployment will be recorded.

Monitoring Period: The position of the catheter tip will be monitored at set intervals using ultrasound imaging to track any migration or dislocation from the initial placement site.

Removal: The catheter will be removed in the operating room immediately prior to the commencement of the scheduled amputation.

02

Conditions studied

  • Primary Condition: Nerve Block
  • Secondary Condition: Catheter Displacement
  • Focus of Study: Sciatic Nerve

Keywords

  • Sciatic Nerve Block
  • Peripheral Nerve Catheter
  • Catheter Migration
  • Internal Fixation Device
  • Proof-of-Concept Study
03

In context

Lead sponsor

Nordsjaellands Hospital is the lead sponsor of 89 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years or older
  • Scheduled for elective transfemoral amputation
  • Able and willing to provide

Exclusion criteria

Exclusion Criteria:

  • Known allergy to local anesthetics
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Sciatic Nerve Catheter

    All participants will receive the prototype fixation catheter placed near the sciatic nerve distal to the planned amputation line.

    Device: Novel Internal Fixation Nerve Block Catheter - Sciatic Nerve

  • Experimental
    Saphenous Nerve Catheter

    If the planned amputation line is high enough on the femur to allow for distal placement, participants will also receive a second prototype fixation catheter near the saphenous nerve.

    Device: Novel Internal Fixation Nerve Block Catheter - Saphenous nerve

Interventions

  • DeviceNovel Internal Fixation Nerve Block Catheter - Sciatic Nerve

    A peripheral nerve block catheter prototype featuring internal fixation to prevent dislocation and a rapid-deployment system. Catheters are placed under ultrasound guidance.

  • DeviceNovel Internal Fixation Nerve Block Catheter - Saphenous nerve

    Placement of the saphenous catheter is contingent upon an amputation line that allows for placement below the surgical site (distal to the cut).

06

What researchers measure

Primary outcomes

  1. Catheter Dislocation Distance

    The absolute distance (in millimeters) between the position of the catheter delivery orifice at initial placement and its position just before removal. The position is verified by ultrasound imaging using hydrodissection with a local anesthetic bolus to identify the orifice.

    Time frame: From initial placement (Day 0) to immediately prior to amputation surgery (typically 48-72 hours).

Secondary outcomes

  1. Time on Task

    Time required for catheter placement, measured from initiation of skin disinfection to final skin fixation using a stopwatch (seconds).

    Time frame: At time of procedure (Day 0)

  2. Primary Placement Success Rate

    Proportion of successful primary catheter placements, defined as the accurate position of the delivery orifice verified by ultrasound

    Time frame: At time of procedure (Day 0)

  3. Catheter Clinical Performance (Sensory Block)

    Sensitivity to a cooled vial (5°C) over the cutaneous innervation area (Tibial/Peroneal for sciatic; Saphenous for saphenous nerve).

    Time frame: Day 0 (preprocedure and postprocedure), day 1, day 2, and day 3.

  4. Catheter Retraction Force

    The force required for catheter removal, measured with a digital handheld force transducer (Newtons).

    Time frame: Day 3 (just before surgery)

  5. Pain Intensity (NRS)

    Participant-reported pain at rest using a Numeric Rating Scale (0-10, where 0 is no pain and 10 the worst thinkable pain)

    Time frame: Day 0, Day 1, Day 2 and Day 3

  6. Cumulative Opioid Consumption

    Total intravenous (IV) morphine equivalents administered while the catheter is in place.

    Time frame: Day 0 to day 3 (Entire study duration)

  7. Incidence of Adverse Events

    Number and nature of complications including infection, back-leakage, or device-related issues.

    Time frame: Day 0 to day 3 (Entire study duration)

07

Study locations

1 site
08

References and documents

Publications

  • Carvalho BY, Mariano ER. Continuous vs. single-injection peripheral nerve blocks: A prospective cohort study comparing procedural time and personnel cost. Open Anesthesiol J. 2015;9:1-5.
  • Martin N, Davis CJ. Evidence from masked-priming that initial identification of brand names is via abstract letter identities. Br J Psychol. 2019 Nov;110(4):745-768. doi: 10.1111/bjop.12362. Epub 2019 Jan 4. PubMed 30613945 ↗
  • Baillie J, Lankshear A. PATIENTS' AND RELATIVES' EXPERIENCES OF PERITONITIS WHEN USING PERITONEAL DIALYSIS. J Ren Care. 2015 Sep;41(3):177-86. doi: 10.1111/jorc.12118. Epub 2015 Feb 27. PubMed 25727142 ↗
  • Hauritz RW, Hannig KE, Balocco AL, Peeters G, Hadzic A, Borglum J, Bendtsen TF. Peripheral nerve catheters: A critical review of the efficacy. Best Pract Res Clin Anaesthesiol. 2019 Sep;33(3):325-339. doi: 10.1016/j.bpa.2019.07.015. Epub 2019 Jul 22. PubMed 31785718 ↗
  • Ilfeld BM. Continuous Peripheral Nerve Blocks: An Update of the Published Evidence and Comparison With Novel, Alternative Analgesic Modalities. Anesth Analg. 2017 Jan;124(1):308-335. doi: 10.1213/ANE.0000000000001581. PubMed 27749354 ↗

Individual participant data

Plan to share: Undecided — Whether individual participant data will be shared has not yet been determined. The study evaluates novel design principles and mechanical fixation mechanisms for which intellectual property (IP) protection is currently being sought or finalized. A decision regarding the sharing of de-identified data will be made once the proprietary interests of the device design are fully secured and the primary feasibility analysis is complete.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Feb 2026; primary completion for Aug 2026, 6 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 15, 2026
First posted
Feb 4, 2026
StartEst.
Feb 2026
Primary completionEst.
Aug 2026
CompletionEst.
Nov 2026
Last update
Feb 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07385872
Lead sponsor
Nordsjaellands Hospital
Collaborators
Hvidovre University Hospital, Nordstar Medical
Responsible party
Sponsor
First posted
Feb 4, 2026
Start date
Feb 2026 (estimated)
Primary completion
Aug 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Feb 4, 2026

Study contacts

Christoffer C Jørgensen, MD, PhD
Contact
christoffer.calov.joergensen.01@regionh.dk
+45 48296659
Kai H Lange, MD, PhD
Contact
kai.henrik.wiborg.lange@regionh.dk
+45 48294252
Christoffer C Jørgensen, MD, PhD
principal investigator · Nordsjaellands Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion